Clinical Trial

Pharmacokinetic Study of Therapeutic Plasma Exchange

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to characterize the pharmacokinetics of one or more ICIs during and after TPE/PLEX in patients with severe irAEs.
Trial Details
NCT Number NCT07756242
Lead Sponsor University of Chicago
Conditions Immune-related Adverse Event
Enrollment 15 participants
Start Date 2026-11
Primary Completion 2027-11 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-08-10